EUVIMEDEUVIMED entdecken
Crossref

Does preoperative antiresorptive medication affect total temporomandibular joint replacement outcomes?

Mahdi Zakeri, Jordan Manley, Patrick Louis, Brian Kinard

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology · 2026

DOI: 10.1016/j.oooo.2025.08.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2026. Verfasst von Mahdi Zakeri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral & Maxillofacial Surgery, Orthognathic and Temporomandibular Joint Surgery, University of Alabama at Birmingham, Birmingham, AL, US…. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Bone Density Conservation Agents, Temporomandibular Joint Disorders, Osteoporosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the clinical and radiographic outcomes of temporomandibular joint (TMJ) total joint replacement (TJR) in osteoporotic patients receiving preoperative antiresorptive therapy. STUDY DESIGN: This retrospective chart review included osteoporotic patients who underwent TMJ TJR at a single institution. Data collected included demographics, medical history, type and duration of antiresorptive therapy, surgical details, and postoperative outcomes. Clinical parameters included range of motion (ROM), joint noise, and dietary limitations. Radiographic assessment evaluated periprosthetic bone changes and implant stability. Descriptive statistics summarized outcomes. RESULTS: Eight patients (62.5% female; mean age 61.5 ± 11.4 years) with osteoporosis and history of antiresorptive therapy were analyzed. The average therapy duration was 3.75 ± 3 years. Mean clinical and CBCT follow-up was 16 ± 9.6, and 6.5 ± 3.6 months respectively. No patients developed medication-related osteonecrosis of the jaw (MRONJ), prosthetic failure, hardware loosening, or periprosthetic osteolysis. Functional outcomes were favorable, with mean postoperative ROM of 35.1 ± 4.8 mm and no joint noise. CONCLUSION: Preoperative antiresorptive therapy in osteoporotic patients does not appear to increase the risk of complications or impair functional outcomes following TMJ TJR. Larger sample sizes, possibly through multicenter investigations, are critical to establishing high-level evidence regarding its safety and efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, ReplacementBone Density Conservation AgentsTemporomandibular Joint DisordersOsteoporosisTemporomandibular JointHumansFemaleRetrospective StudiesMiddle AgedMaleTreatment OutcomeRange of Motion, ArticularCone-Beam Computed TomographyAgedJoint Prosthesis

Substanzen

Bone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Oral & Maxillofacial Surgery, Orthognathic and Temporomandibular Joint Surgery, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: zakerim@myumanitoba.ca.
  • School of Dentistry, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Oral & Maxillofacial Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Oral & Maxillofacial Surgery, Department of Orthodontics, University of Alabama at Birmingham, Birmingham, AL, USA.

Zitieren

APA

Zakeri, M., Manley, J., Louis, P., & Kinard, B. (2026). Does preoperative antiresorptive medication affect total temporomandibular joint replacement outcomes?. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. https://doi.org/10.1016/j.oooo.2025.08.018

Vancouver

Zakeri M, Manley J, Louis P, Kinard B. Does preoperative antiresorptive medication affect total temporomandibular joint replacement outcomes?. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2026. doi:10.1016/j.oooo.2025.08.018

BibTeX
@article{Zakeri2026,
  author = {Zakeri, Mahdi and Manley, Jordan and Louis, Patrick and Kinard, Brian},
  title = {Does preoperative antiresorptive medication affect total temporomandibular joint replacement outcomes?},
  journal = {Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology},
  year = {2026},
  doi = {10.1016/j.oooo.2025.08.018}
}
Kostenlos starten →